Skip to main content

View full-text article in PMC

. 2020 Sep 15;13(12):100855. doi: 10.1016/j.tranon.2020.100855

Table 4.

Benign gene mutations identified in this study by correlation analysis.

Gene	Type	Clinical features
		LDH		P	UA		P	LDH & UA		P	Prognosis		P
		>N	N	P	>N	N	P	>N	others	P	Benign	Poor	P
CD79A	MUT	8	1	0.127	8	1	0.127	0	9	0.045	8	1	0.127
CD79A	WT	1	2	0.127	1	2	0.127	2	1	0.045	1	2	0.127
MYD88	MUT	7	1	0.236	7	1	0.067	0	8	0.091	7	1	0.236
MYD88	WT	2	2	0.236	1	3	0.067	2	2	0.091	2	2	0.236
KLF2	MUT	7	1	0.236	7	1	0.067	0	8	0.091	7	1	0.236
KLF2	WT	2	2	0.236	1	3	0.067	2	2	0.091	2	2	0.236
CD79A and/or MYD88	MUT	1	9	0.045	2	8	0.067	0	10	0.015	9	1	0.045
CD79A and/or MYD88	WT	2	0	0.045	2	0	0.067	2	0	0.015	0	2	0.045
CD79A and/or KLF2	MUT	1	9	0.045	2	8	0.067	0	10	0.015	9	1	0.045
CD79A and/or KLF2	WT	2	0	0.045	2	0	0.067	2	0	0.015	0	2	0.045

Abbreviations: LDH, lactate dehydrogenase; UA, uric acid; N, normal value; >N, higher than normal value; MUT, mutation; WT, wild-type.